Sagimet Biosciences Inc. <SGMT.O>: Barclays Raises to Overweight From Equal-Weight; Raises Target Price to $18 From $8
SGMT•Related News
Trisalus Life Sciences, Inc. <TLSI.O>: H.C. Wainwright Initiates Coverage With Buy Rating and Target Price $11
TLSI•
Apple expected to unveil first folding phone, with new CEO Ternus in command
AAPL•
Plains All American buys remaining EPIC Crude Holdings stake, takes full ownership of Cactus III pipeline operator
PAA•
Hercules Capital adviser tops $2.3 billion in investable capital
HTGC•
Starling Oncology forecasts FY2026 revenue of $650-670 million
STLN•